Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)
|
October 11, 2013
Safety and effectiveness of a glistening-free single-piece hydrophobic acrylic intraocular lens (enVista)
Mark Packer, Luther Fry, Kevin T Lavery, et al.
The American Journal of Cardiology
|
January 4, 2001
Effect of preinfarction angina pectoris on outcome in patients with acute myocardial infarction treated with primary angioplasty (results from the Myocardial Infarction Registry
R Zahn, R Schiele, S Schneider, et al.
European Heart Journal
|
September 11, 2001
Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA 1+2) Registries and the Myocardial Infarction Registry (MIR)
M Gottwik, R Zahn, R Schiele, et al.
Herz
|
January 6, 2001
Transfer of patients with acute myocardial infarction for primary or acute angioplasty from hospitals without the facilities to perform angioplasty. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR)
R Zahn, R Schiele, S Schneider, et al.
American Heart Journal
|
June 30, 2001
Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis
R Zahn, R Schiele, A K Gitt, et al.
Journal of the American College of Cardiology
|
June 13, 2001
Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction Registry
R Zahn, R Schiele, S Schneider, et al.
VASA. Zeitschrift Fur Gefasskrankheiten
|
December 26, 2003
[DRG-based cost analysis of inpatient conservative treatment of stage III/IV peripheral arterial occlusive disease]
H Heidrich, W Rogatti, E Altmann, et al.
The Journal of Invasive Cardiology
|
June 1, 2001
Primary angioplasty versus no reperfusion therapy in patients with acute myocardial infarction and a pre-hospital delay of > 12-24 hours: results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR)
R Zahn, R Schiele, S Schneider, et al.
Journal of the American College of Cardiology
|
December 29, 2000
Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR)
R Zahn, R Schiele, S Schneider, et al.
European Heart Journal
|
September 7, 2000
Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction; a phase II dose escalation, randomized, double-blind study
E Ronner, H A van Kesteren, P Zijnen, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Clinical Ophthalmology (Auckland, N.Z.)
|
October 11, 2013
Safety and effectiveness of a glistening-free single-piece hydrophobic acrylic intraocular lens (enVista)
Mark Packer, Luther Fry, Kevin T Lavery, et al.
The American Journal of Cardiology
|
January 4, 2001
Effect of preinfarction angina pectoris on outcome in patients with acute myocardial infarction treated with primary angioplasty (results from the Myocardial Infarction Registry
R Zahn, R Schiele, S Schneider, et al.
European Heart Journal
|
September 11, 2001
Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA 1+2) Registries and the Myocardial Infarction Registry (MIR)
M Gottwik, R Zahn, R Schiele, et al.
Herz
|
January 6, 2001
Transfer of patients with acute myocardial infarction for primary or acute angioplasty from hospitals without the facilities to perform angioplasty. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR)
R Zahn, R Schiele, S Schneider, et al.
American Heart Journal
|
June 30, 2001
Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis
R Zahn, R Schiele, A K Gitt, et al.
Journal of the American College of Cardiology
|
June 13, 2001
Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction Registry
R Zahn, R Schiele, S Schneider, et al.
VASA. Zeitschrift Fur Gefasskrankheiten
|
December 26, 2003
[DRG-based cost analysis of inpatient conservative treatment of stage III/IV peripheral arterial occlusive disease]
H Heidrich, W Rogatti, E Altmann, et al.
The Journal of Invasive Cardiology
|
June 1, 2001
Primary angioplasty versus no reperfusion therapy in patients with acute myocardial infarction and a pre-hospital delay of > 12-24 hours: results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR)
R Zahn, R Schiele, S Schneider, et al.
Journal of the American College of Cardiology
|
December 29, 2000
Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR)
R Zahn, R Schiele, S Schneider, et al.
European Heart Journal
|
September 7, 2000
Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction; a phase II dose escalation, randomized, double-blind study
E Ronner, H A van Kesteren, P Zijnen, et al.
Page
of 8